1. Home
  2. RGNT vs EQS Comparison

RGNT vs EQS Comparison

Compare RGNT & EQS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Regentis Biomaterials Ltd. Ordinary Shares

RGNT

Regentis Biomaterials Ltd. Ordinary Shares

HOLD

Current Price

$0.72

Market Cap

14.3M

Sector

Health Care

ML Signal

HOLD

Logo Equus Total Return Inc.

EQS

Equus Total Return Inc.

SELL

Current Price

$0.60

Market Cap

12.3M

Sector

Finance

ML Signal

SELL

Company Overview

Basic Information
Metric
RGNT
EQS
Founded
2004
1991
Country
Israel
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Finance Companies
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
14.3M
12.3M
IPO Year
2022
1995

Fundamental Metrics

Financial Performance
Metric
RGNT
EQS
Price
$0.72
$0.60
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
★ 43.5K
7.6K
Earning Date
09-11-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.81
$0.53
52 Week High
$15.50
$2.05

Technical Indicators

Market Signals
Indicator
RGNT
EQS
Relative Strength Index (RSI) 21.62 43.24
Support Level N/A N/A
Resistance Level $2.52 $1.05
Average True Range (ATR) 0.15 0.06
MACD -0.03 0.01
Stochastic Oscillator 3.85 34.99

Price Performance

Historical Comparison
RGNT
EQS

About RGNT Regentis Biomaterials Ltd. Ordinary Shares

Regentis Biomaterials Ltd is a regenerative medicine company dedicated to developing tissue repair solutions that restore health and enhance the quality of life of patients. It is focused on orthopedic treatments using its Gelrin platform based on degradable hydrogel implants to regenerate damaged or diseased tissue (inflamed cartilage and bone tissue). Gelrin is a hydrogel matrix of polyethylene glycol diacrylate and denatured fibrinogen (a biologically inactivated protein that normally has a role in blood clotting). Its product is GelrinC, a cell-free, off-the-shelf hydrogel that is cured into an implant in the knee for the treatment of painful injuries to articular knee cartilage.

About EQS Equus Total Return Inc.

Equus Total Return Inc is a United States-based closed-end management investment company. The company invests mainly in companies pursuing growth either through acquisition or organically, leveraged buyouts, management buyouts, and recapitalizations of existing businesses or special situations, and achieves capital appreciation by making investments in equity and equity-oriented securities issued by privately-owned companies or smaller public companies in transactions.

Share on Social Networks: